KFG
PFE icon

Kelly Financial Group’s Pfizer PFE Stock Holding History

Kelly Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$437K Buy
18,133
+164
+0.9% +$4.29K 0.1% 57
2026
Q1 		$505K Sell
17,969
-566
-3% -$15.1K 0.13% 55
2025
Q4 		$462K Buy
18,535
+68
+0.4% +$1.72K 0.12% 50
2025
Q3 		$471K Buy
18,467
+69
+0.4% +$1.7K 0.12% 50
2025
Q2 		$446K Buy
18,398
+1,012
+6% +$23.6K 0.13% 50
2025
Q1 		$441K Buy
+17,386
New +$455K 0.14% 52

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kelly Financial Group's PFE Position: Q2 2026 in Review

Kelly Financial Group increased its Pfizer (PFE) stake by 0.91% in Q2 2026, buying an estimated $4.29K and bringing the position to 18,133 shares worth $437K. The position accounts for 0.1% of the portfolio, ranked #57.

Kelly Financial Group first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $505K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kelly Financial Group held 18,133 shares of Pfizer worth $437K as of Q2 2026.
  • Kelly Financial Group bought 164 Pfizer shares in Q2 2026, an estimated $4.29K.
  • Pfizer made up 0.1% of Kelly Financial Group's portfolio in Q2 2026, its #57 holding.
  • Kelly Financial Group first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • Kelly Financial Group's Pfizer position peaked at $505K in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kelly Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.